Serrapeptase has not been shown to directly lower cholesterol levels. No published clinical trials demonstrate that this enzyme reduces LDL, total cholesterol, or triglycerides in humans. However, serrapeptase does interact with cardiovascular health in other ways, which likely explains why it keeps appearing in conversations about heart health and cholesterol.
What Serrapeptase Actually Does
Serrapeptase (also called serratiopeptidase) is a proteolytic enzyme, meaning it breaks down proteins. It was originally isolated from bacteria living in the gut of silkworms, and it’s now produced through fermentation for use as a supplement. Its primary documented effects are reducing inflammation and breaking down certain types of protein-based tissue.
The enzyme works mainly by interfering with the body’s inflammatory pathways. It has a strong affinity for COX-I and COX-II, the same inflammation-driving enzymes that drugs like ibuprofen target. Through this pathway, it influences the production of prostaglandins and thromboxanes, both of which play roles in inflammation, pain, and blood clotting. It also reduces lipid peroxidation, a process where fats in your cells get damaged by oxidative stress. Lipid peroxidation is a contributor to arterial damage, but it’s a different issue from having high cholesterol numbers on a blood test.
The Atherosclerosis Connection
The reason serrapeptase gets linked to cholesterol is its reported effect on arterial plaques. Atherosclerotic plaques are buildups of cholesterol, fats, calcium, and fibrous tissue inside artery walls. Because serrapeptase is a protein-dissolving enzyme, it has been investigated for its ability to break down the fibrous (protein-based) components of these plaques. Some laboratory and preliminary research suggests the enzyme can dissolve plaques through this proteolytic action.
This is an important distinction. Breaking down existing plaque deposits in arteries is not the same as lowering circulating cholesterol in your blood. Your cholesterol numbers on a lipid panel measure how much cholesterol is traveling through your bloodstream. Serrapeptase’s potential benefit, if confirmed in larger human studies, would be more about addressing damage that has already occurred in your arteries rather than preventing cholesterol from accumulating in the first place. Think of it this way: statins reduce the raw material floating in your blood, while serrapeptase theoretically chips away at deposits already stuck to the walls.
That said, the evidence for plaque dissolution in humans remains limited. Most of the supportive data comes from laboratory studies and small trials, not the kind of large-scale clinical research that would make this a reliable treatment recommendation.
Why It Might Still Support Heart Health
Even without a direct cholesterol-lowering effect, serrapeptase’s anti-inflammatory properties could be relevant to cardiovascular risk. Chronic inflammation is now understood to be a major driver of heart disease, independent of cholesterol levels. By reducing inflammatory markers and decreasing lipid peroxidation (oxidative damage to fats), serrapeptase may offer some cardiovascular benefit through a completely different mechanism than cholesterol reduction.
Its effect on blood clotting is another piece of the cardiovascular puzzle. Serrapeptase slows blood clotting, which could theoretically reduce the risk of clot-related events like heart attacks and strokes. This is also why it carries risks for certain people, but the anticoagulant property does place it in the broader category of supplements with cardiovascular relevance.
Typical Dosage in Research
Most studies on serrapeptase use 10 mg taken three times daily (every eight hours). That 10 mg dose is roughly equivalent to 20,000 enzymatic units, which is how many supplement labels express the potency. The broader dosage range seen in research is 10 to 60 mg per day. Supplements marketed for cardiovascular support sometimes use higher doses, but these aren’t backed by stronger evidence.
Serrapeptase needs to be taken on an empty stomach to work as intended. If it encounters food in your digestive tract, it will break down dietary proteins instead of being absorbed into the bloodstream where it can have systemic effects. Enteric-coated capsules, which resist stomach acid and dissolve in the intestines, are the standard formulation.
Safety Concerns Worth Knowing
Side effects are generally mild and mostly digestive: stomach upset and nausea are the most commonly reported issues. The more serious concern is serrapeptase’s interaction with blood clotting. Because it slows clot formation, it can increase the risk of bruising and bleeding, especially if you’re already taking blood thinners like warfarin, aspirin, or other anticoagulant or antiplatelet medications. The combination of serrapeptase with these drugs is considered a moderate interaction.
If you have a bleeding disorder, serrapeptase could make it worse. And if you have surgery planned, you should stop taking it at least two weeks beforehand to allow your clotting function to normalize.
There are no well-documented interactions specifically between serrapeptase and statins (cholesterol-lowering medications). They work through entirely different mechanisms, so taking both is unlikely to cause a pharmacological conflict. Still, if you’re on statins and considering adding serrapeptase, the conversation with your prescriber is about whether the supplement adds any meaningful benefit on top of a medication with far stronger evidence behind it.
Nattokinase: The Enzyme People Confuse It With
Serrapeptase often gets mentioned alongside nattokinase, another enzyme supplement popular in cardiovascular health circles. Nattokinase, derived from fermented soybeans, has a more established connection to cardiovascular markers. It works primarily as a fibrinolytic enzyme, meaning it dissolves fibrin, a protein involved in blood clot formation. Some people take both enzymes together, and combination supplements are widely available.
Neither enzyme is a substitute for conventional cholesterol management. If your primary goal is lowering your LDL or total cholesterol numbers, the evidence points clearly toward dietary changes, exercise, and, when necessary, prescription medications. Serrapeptase may have a supporting role in cardiovascular health through inflammation and plaque-related pathways, but it won’t move the needle on a standard lipid panel.